Vivimed Labs (NSE:VIVIMEDLAB) Book Value per Share: ₹0.00 (As of Dec. 2025)


NSE:VIVIMEDLAB Vivimed Labs Ltd NSE:VIVIMEDLAB
42 GF Score
Price ₹5.41
GF Value ₹2.55
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Vivimed Labs Book Value per Share?

Vivimed Labs NSE:VIVIMEDLAB 42 Book Value per Share is ₹0.00 as of Dec. 2025. GuruFocus rates NSE:VIVIMEDLAB with a GF Score™ of 42/100 and a GF Value™ of ₹2.55 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Vivimed Labs's book value per share for the quarter that ended in Dec. 2025 was ₹0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Vivimed Labs was 34.50% per year. The lowest was -63.90% per year. And the median was 14.55% per year.

Vivimed Labs's current price is ₹5.41. Its book value per share for the quarter that ended in Dec. 2025 was ₹0.00. Hence, today's PB Ratio of Vivimed Labs is .

During the past 13 years, the highest P/B Ratio of Vivimed Labs was 1.69. The lowest was 0.08. And the median was 0.33.


Vivimed Labs  (NSE:VIVIMEDLAB) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Vivimed Labs Book Value per Share Related Terms


Vivimed Labs Book Value per Share Historical Data

* Premium members only.

The historical data trend for Vivimed Labs's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivimed Labs Book Value per Share Chart

Vivimed Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.05 43.94 4.76 -0.66 -4.24

Vivimed Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -4.24 0.00 -5.79 0.00

NSE:VIVIMEDLAB vs ZTS, UTHR: Book Value per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vivimed Labs's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivimed Labs PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivimed Labs's PB Ratio distribution charts can be found below:

* The bar in red indicates where Vivimed Labs's PB Ratio falls into.


NSE:VIVIMEDLAB
42GF Score
Vivimed Labs Ltd NSE:VIVIMEDLAB
Book Value per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivimed Labs Book Value per Share Calculation

Vivimed Labs's Book Value Per Share for the fiscal year that ended in Mar. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-351.7-0.0)/82.9
=-4.24

Vivimed Labs's Book Value Per Share for the quarter that ended in Dec. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(N/A-0.0)/82.9
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of ₹0.00 mean?
Vivimed Labs (NSE:VIVIMEDLAB) has a Book Value per Share of ₹0.00 as of Dec. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Vivimed Labs and its competitors.
Is Vivimed Labs' Book Value per Share too high?
Vivimed Labs' current Book Value per Share is ₹0.00. Overall, Vivimed Labs has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vivimed Labs' Book Value per Share compare to ZTS and UTHR?
Vivimed Labs' Book Value per Share of ₹0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Drug Manufacturers company?
A good Book Value per Share depends on the Drug Manufacturers industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Vivimed Labs and its competitors. Vivimed Labs's current Book Value per Share is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivimed Labs stock overvalued right now?
Based on GuruFocus' analysis, Vivimed Labs (NSE:VIVIMEDLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.55, compared to a current price of ₹5.41 — trading 112.2% above its estimated fair value. The current Book Value per Share is ₹0.00. Vivimed Labs' overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Vivimed Labs (NSE:VIVIMEDLAB), the current Book Value per Share is ₹0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivimed Labs (NSE:VIVIMEDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vivimed Labs stock appears to be overvalued. The current stock price of ₹5.41 is trading 112.2% above its estimated GF Value™ of ₹2.55. GuruFocus considers Vivimed Labs to be Significantly Overvalued.

Key valuation signals for NSE:VIVIMEDLAB:

  • Book Value per Share: ₹0.00
  • GF Value™: ₹2.55 vs. price of ₹5.41 (112.2% above fair value)
  • GF Score™: 42/100 with 7 warning signs

No single metric tells the full story. See the NSE:VIVIMEDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vivimed Labs Business Description

Other Exchanges 532660:India
Address Green Lands, Beside The Plaza Hotel, D.No. 6-3-866/1/G1, 3rd & 4th Floor, GMR Towers, Begumpet, Hyderabad, TG, IND, 500016
Vivimed Labs Ltd is an India-based company that is engaged in the Business of Active pharmaceutical ingredients, Intermediates, Nutraceutical ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals, and Retail Branded Formulation manufacturing. The company has three reportable segments: the Speciality Chemicals Business, the Pharma Business, and others. The majority of revenue is earned through the Pharma business.
42GF Score

Get the complete analysis for NSE:VIVIMEDLAB

Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5.41
Price
₹2.55
GF Value